Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program

Keywords

Diabetes mellitus, Single-nucleotide polymorphism, Wolfram syndrome, Type 2 diabetes, Medicine

References

• Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 DiabetesEleftheria Zeggini, Michael N. Weedon, Cecilia M. Lindgren — 2007
• Genome–wide association studies provide new insights into type 2 diabetes aetiologyTimothy M. Frayling — 2007
• Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates.F. Hsieh, Philip W. Lavori — 2000
• A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)Hiroshi Inoue, Yukio Tanizawa, Jon Wasson — 1998
• Common variants in WFS1 confer risk of type 2 diabetesManjinder S. Sandhu, Michael N. Weedon, Katherine A. Fawcett — 2007
• Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride LevelsRicha Saxena, Benjamin F. Voight, Valeriya Lyssenko — 2007
• Replication of the association between variants in the WFS1 gene and risk of type 2 diabetes in European populationsPaul W. Franks, Olov Rolandsson, S. L. Debenham — 2007
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.Diabetes Prevention Program Research Group — 2002
• Type 2 Diabetes–Associated Missense Polymorphisms KCNJ11 E23K and ABCC8 A1369S Influence Progression to Diabetes and Response to Interventions in the Diabetes Prevention ProgramJosé C. Florez, Kathleen A. Jablonski, Steven E. Kahn — 2007

Cited by

• Role of WFS1 in Regulating Endoplasmic Reticulum Stress Signaling: A DissertationSonya G. Fonseca — 2009
• A WFS1 haplotype consisting of the minor alleles of rs752854, rs10010131, and rs734312 shows a protective role against type 2 diabetes in Russian patients.Dimitry A. Chistiakov, Dmitry Khodyrev, С. А. Сметанина — 2010
• Therapeutic Use of Metformin in Prediabetes and Diabetes PreventionUlrike Gottwald‐Hostalek, Mike Gwilt, Steven Hildemann — 2015
• Association study of the effect of WFS1 polymorphisms on risk of type 2 diabetes in Japanese population.Masaki Mita, Kazuaki Miyake, Masako Zenibayashi — 2008
• [Pharmacogenetics of insulin secretagogue antidiabetics].Gábor Winkler, László Gerő — 2011
• Association of Type 2 Diabetes Susceptibility Loci With One-Year Weight Loss in the Look AHEAD Clinical TrialInga Peter, Jeanne M. McCaffery, Alyson Kelley-Hedgepeth — 2012
• Genetic variants affecting incretin sensitivity and incretin secretionKarsten Müssig, Harald Staiger, Fausto Machicao — 2010
• Obesity and diabetes genes are associated with being born small for gestational age: Results from the Auckland Birthweight Collaborative studyAngharad R. Morgan, John Thompson, Rinki Murphy — 2010
• Wolfram Syndrome in the Japanese Population; Molecular Analysis of WFS1 Gene and Characterization of Clinical FeaturesKimie Matsunaga, Katsuya Tanabe, Hiroshi Inoue — 2014
• Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulationThomas Sparsø, Gary L. Andersen, Anders Albrechtsen — 2008
• New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms.Silke Schäfer, Fausto Machicao, Andreas Fritsche — 2011
• Stress hypERactivation in the β-cellSonya G. Fonseca, Fumihiko Urano, Mark Burcin — 2010
• Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traitsN Maneka G De Silva, Timothy M. Frayling — 2010
• The binary switch that controls the life and death decisions of ER stressed beta cellsChristine M. Oslowski, Fumihiko Urano — 2010
• A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretionSilke Schäfer, Karsten Müssig, Harald Staiger — 2009
• Pharmacogenetics of Anti-Diabetes DrugsJohanna K. DiStefano, Richard M. Watanabe — 2010
• Individualisierte Prävention des Typ-2-DiabetesNorbert Stefan, Andreas Fritsche, Hans‐Ulrich Häring — 2009
• Current Developments in Wolfram SyndromeM Ashraf Ganie, Dattatray Bhat — 2009
• Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes?José C. Florez — 2008
• Modifying the Diabetes Prevention Program to Adolescents in a School Setting: A Feasibility StudyLori Candela, Antonio P. Gutierrez, Janet S. Dufek — 2012

Related papers

• c.2425G>A mutation in the WFS1 gene associated with Wolfram syndrome: a case reportLiu Ying — 2018
• Wolfram Syndrome: A Rare Genetic disorder affecting Multiple Organ SystemsBhagya Sree Lekha Annamneedi, Abhiram Sorra, Vinod Kumar Mugada — 2023
• Genetic variations in the WFS1 gene in Japanese with type 2 diabetes and bipolar disorder.Takanori Kawamoto, Yukio Horikawa, Takeshi Tanaka — 2004
• Analysis of perforin and granzyme B gene single nucleotide polymorphisms in Han population of Chongqing.Wen Yi-ni — 2010
• Predicting late-stage age-related macular degeneration by integrating marginally weak SNPs in GWA studiesXueping Zhou, Jipeng Zhang, Ying Ding — 2023
• Genetic variations in chemoattractant receptor expressed on Th2 cells (CRTH2) is associated with asthma susceptibility in Chinese childrenJinhui Wang, Yong-chen Xu, Hong Zhao — 2009
• Identification of two novel single nucleotide polymorphisms in the promoter of the human interleukin-18 receptor alpha.Sandra Pinto-Cardoso, Leigh Keen, Josie Bidwell — 2004
• Ethnic differences in the linkage disequilibrium and distribution of single-nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases.Maggie Ng, Ying Wang, Wing‐Yee So — 2004
• Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel disease.Katherine Y. King, Anne Marie Moody, Scott Fisher — 2003